Abbott Laboratories (ABT) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Abbott Laboratories · Health Care · ref. ETF XLV · 130 calls · price $111.59
What the company does: Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions.
📈 Abbott Laboratories (ABT) stock price
$111.59-15.1% over range
Aug 28, 25low $82.56 · high $136.62Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 17 analysts
📊 JPI status : Abbott Laboratories has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 ABT price target & analyst consensus — price $112
The price target · all analysts combined (17 targets)
Highest target · 1 firm of 17$143+28.1%
Median target · of 17 targets$120+7.5%
Lowest target · 1 firm of 17$112+0.4%
Current price$111.59
Where these 17 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
17100%
$112 ↔ $143
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Wolfe Research — 67% of its targets hit on this sector (46 calls tested). It aims for $130 (+17 %), call made on August 14, 2026, maturing on August 14, 2027 (14 d ago).
The 10 reliable analysts
$123+10 %
The 7 other firms
$120+7.5 %
How to read it: the 10 reliable firms are not filtered by optimism — 10 aim above the price, 0 below, hence their $123 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 17 ratings (last 6 months)
Strong Buy00%
Buy17100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ABT price target all
All 16 calls, one by one, with our verdict on each firm.
→ See all 16 targets, analyst by analyst💡 The best analysts on ABT most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ABT? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Abbott Laboratories? The JPI assistant answers using our backtest data.
💰 Abbott Laboratories dividend: yield, history & growth › open the full page
2.65%annual yield
📈 Steady dividend — 10 yrs of consecutive dividend increases
That's ~$2.44 per share per year.
📈 Abbott Laboratories fundamentals: valuation, margins & growth › open the full page
P/E 37.0Net margin 11.6 %Revenue growth +13.0 %Fairly valued
🏛️ Abbott Laboratories insider buying: who's buying and how much › open the full page
3 insiders bought3 buys / 6 mo $1.3M👥 Cluster buy
🔎 Detailed analyses
🏛️ Which US Congress members hold Abbott Laboratories (ABT)?
9 Congress members have disclosed ABT buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Dean Phillips 3× · 39%Kathy Manning 3× · 43%David McKinley 2× · 38%Robert Wittman 2× · 47%Carol Miller 2× · 25%Richard Allen 2× · 42%Michael Burgess 1× · 40%John Curtis 1× · 62%Greg Stanton 1× · 48%
✅ Historical analyst reliability on ABT
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| BMO Capital ↗ | 100% | +18.6% | 3 |
| William Blair ↗ | 100% | +16.9% | 2 |
| Deutsche Bank ↗ | 100% | +15.4% | 3 |
| Argus Research ↗ | 100% | +14.9% | 4 |
| JP Morgan ↗ | 89% | +13.4% | 9 |
| Credit Suisse | 85% | +18.9% | 13 |
| Jefferies ↗ | 81% | +9.2% | 27 |
| Morgan Stanley ↗ | 77% | +9.9% | 30 |
| UBS ↗ | 76% | +9.2% | 17 |
| Stifel ↗ | 75% | +8.1% | 20 |
See the other 14 firms
| BTIG ↗ | 35% | -8.4% | 17 |
| Evercore ISI Group ↗ | 38% | -4.3% | 13 |
| B of A Securities ↗ | 40% | -4.7% | 5 |
| Citigroup ↗ | 46% | +0.7% | 26 |
| RBC Capital ↗ | 47% | -1.7% | 15 |
| TD Cowen ↗ | 50% | -0.6% | 8 |
| CFRA | 50% | +9.8% | 2 |
| Wells Fargo ↗ | 54% | +4.0% | 26 |
| Goldman Sachs ↗ | 60% | +5.6% | 5 |
| Barclays ↗ | 63% | +5.3% | 19 |
| Raymond James ↗ | 64% | +5.6% | 28 |
| Piper Sandler ↗ | 67% | +0.7% | 3 |
| Wolfe Research ↗ | 67% | +6.6% | 3 |
| Bernstein ↗ | 75% | +5.4% | 4 |
📊 What $1,000 invested in Abbott Laboratories would be worth › open the full page
In short — $1,000 invested in Abbott Laboratories 10 years ago would be worth $2,342 today, i.e. +9%/yr on average. Best year: 2020 (+55%), worst: 2025 (-16%). Price performance, excluding dividends.
If I'd invested $1,000 in Abbott Laboratories
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $657 | -34% |
| 3 years ago | $892 | -11% |
| 5 years ago | $758 | -24% |
Return by year (Abbott Laboratories)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -22% | $780 (-22%) |
| 2025 | -16% | $657 (-34%) |
| 2024 | +16% | $765 (-24%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Abbott Laboratories
Loading news…
📋 All analyst calls on ABT
Filtered on — · ✕ show all
▲ Buy · 🎯$135
Price at call : $114.1 — upside +18%
Today : $111.59 — upside +21%
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Aug 25, 27
matures : Aug 25, 27
▲ Buy · 🎯$125
Price at call : $110.37 — upside +13%
Today : $111.59 — upside +12%
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Aug 14, 27
matures : Aug 14, 27
Wolfe Research ↗
Aug 13, 26
▲ Outperform · 🎯$130
Price at call : $111.25 — upside +17%
Today : $111.59 — upside +16%
🎯 on ABT : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
▲ Buy · 🎯$125
Price at call : $108 — upside +16%
Today : $111.59 — upside +12%
🎯 on ABT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
▲ Buy · 🎯$112
Price at call : $101.66 — upside +10%
Today : $111.59 — upside +0%
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
Piper Sandler ↗
Jul 17, 26
▲ Overweight · 🎯$118
Price at call : $101.66 — upside +16%
Today : $111.59 — upside +6%
🎯 on ABT : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
▲ Overweight · 🎯$120
Price at call : $101.66 — upside +18%
Today : $111.59 — upside +8%
🎯 on ABT : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
Wells Fargo ↗
Jul 17, 26
▲ Overweight · 🎯$112
Price at call : $101.66 — upside +10%
Today : $111.59 — upside +0%
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
See the other 122 calls, newest to oldest
▲ Buy · 🎯$115
Price at call : $101.66 — upside +13%
Today : $111.59 — upside +3%
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
Evercore ISI Group ↗
Jul 17, 26
▲ Outperform · 🎯$120
Price at call : $101.66 — upside +18%
Today : $111.59 — upside +8%
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
RBC Capital ↗
Jul 17, 26
▲ Outperform · 🎯$130
Price at call : $100.68 — upside +29%
Today : $111.59 — upside +16%
🎯 on ABT : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
▲ Buy · 🎯$134
Price at call : $100.68 — upside +33%
Today : $111.59 — upside +20%
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$112
Price at call : $95.84 — upside +17%
Today : $111.59 — upside +0%
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Outperform · 🎯$121
Price at call : $92.18 — upside +31%
Today : $111.59 — upside +8%
🎯 on ABT : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jul 1, 27
matures : Jul 1, 27
Piper Sandler ↗
Jun 22, 26
▲ Overweight · 🎯$115
Price at call : $90.53 — upside +27%
Today : $111.59 — upside +3%
🎯 on ABT : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jun 22, 27
matures : Jun 22, 27
Goldman Sachs ↗
May 31, 26
▲ Buy · 🎯$113
Price at call : $87.78 — upside +29%
Today : $111.59 — upside +1%
🎯 on ABT : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : May 31, 27
matures : May 31, 27
▲ Buy · 🎯$131
Price at call : $92.8 — upside +41%
Today : $111.59 — upside +17%
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
▲ Overweight · 🎯$143
Price at call : $96 — upside +49%
Today : $111.59 — upside +28%
🎯 on ABT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
Piper Sandler ↗
Apr 17, 26
▲ Overweight · 🎯$115
Price at call : $96 — upside +20%
Today : $111.59 — upside +3%
🎯 on ABT : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
Oppenheimer ↗
Apr 17, 26
▲ Outperform · 🎯$115
Price at call : $96 — upside +20%
Today : $111.59 — upside +3%
🎯 on ABT : no call matured yet · 📊 on Health : 44.1% · +0.6% (220 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
RBC Capital ↗
Apr 17, 26
▲ Outperform · 🎯$130
Price at call : $96 — upside +35%
Today : $111.59 — upside +16%
🎯 on ABT : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
▲ Buy · 🎯$120
Price at call : $96.81 — upside +24%
Today : $111.59 — upside +8%
🎯 on ABT : no call matured yet · 📊 on Health : 47.4% · -1.5% (19 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
Evercore ISI Group ↗
Apr 17, 26
▲ Outperform · 🎯$120
Price at call : $96.81 — upside +24%
Today : $111.59 — upside +8%
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
B of A Securities ↗
Apr 17, 26
▲ Buy · 🎯$120
Price at call : $96.81 — upside +24%
Today : $111.59 — upside +8%
🎯 on ABT : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
▲ Buy · 🎯$120
Price at call : $96.81 — upside +24%
Today : $111.59 — upside +8%
🎯 on ABT : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
▲ Buy · 🎯$131
Price at call : $96.81 — upside +35%
Today : $111.59 — upside +17%
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
Goldman Sachs ↗
Apr 9, 26
▲ Buy · 🎯$121
Price at call : $100.3 — upside +21%
Today : $111.59 — upside +8%
🎯 on ABT : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Apr 9, 27
matures : Apr 9, 27
▲ Overweight · 🎯$144
Price at call : $102.72 — upside +40%
Today : $111.59 — upside +29%
🎯 on ABT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$134
Price at call : $101.83 — upside +32%
Today : $111.59 — upside +20%
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Buy · 🎯$131
Price at call : $102.67 — upside +28%
Today : $111.59 — upside +17%
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Mar 31, 27
matures : Mar 31, 27
▲ Buy · 🎯$136
Price at call : $108.14 — upside +26%
Today : $111.59 — upside +22%
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
▲ Overweight · 🎯$142
Price at call : $109.02 — upside +30%
Today : $111.59 — upside +27%
🎯 on ABT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Freedom Broker
Jan 29, 26
▲ Buy · 🎯$120
Price at call : $106.09 — upside +13%
Today : $111.59 — upside +8%
🎯 on ABT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jan 29, 27
matures : Jan 29, 27
▲ Buy · 🎯$140
Price at call : $108.77 — upside +29%
Today : $111.59 — upside +25%
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
▲ Outperform · 🎯$125
Price at call : $108.77 — upside +15%
Today : $111.59 — upside +12%
🎯 on ABT : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
RBC Capital ↗
Jan 23, 26
▲ Outperform · 🎯$135
Price at call : $108.77 — upside +24%
Today : $111.59 — upside +21%
🎯 on ABT : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
Oppenheimer ↗
Jan 23, 26
▲ Outperform · 🎯$132
Price at call : $107.42 — upside +23%
Today : $111.59 — upside +18%
🎯 on ABT : no call matured yet · 📊 on Health : 44.1% · +0.6% (220 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
Evercore ISI Group ↗
Jan 23, 26
▲ Outperform · 🎯$138
Price at call : $107.42 — upside +28%
Today : $111.59 — upside +24%
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
Piper Sandler ↗
Jan 23, 26
▲ Overweight · 🎯$135
Price at call : $107.42 — upside +26%
Today : $111.59 — upside +21%
🎯 on ABT : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
Wells Fargo ↗
Jan 23, 26
▲ Overweight · 🎯$122
Price at call : $107.42 — upside +14%
Today : $111.59 — upside +9%
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
▲ Buy · 🎯$140
Price at call : $107.42 — upside +30%
Today : $111.59 — upside +25%
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
▲ Outperform · 🎯$154
Price at call : $124.64 — upside +24%
Today : $111.59 — upside +38%
🎯 on ABT : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Overweight · 🎯$169
Price at call : $127.78 — upside +32%
Today : $111.59 — upside +51%
🎯 on ABT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
▲ Buy · 🎯$145
Price at call : $123.97 — upside +17%
Today : $111.59 — upside +30%
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Nov 20, 26
matures : Nov 20, 26
▲ Overweight · 🎯$162
Price at call : $128.54 — upside +26%
Today : $111.59 — upside +45%
🎯 on ABT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 17, 26
matures : Oct 17, 26
Raymond James ↗
Oct 16, 25
▲ Outperform · 🎯$146
Price at call : $128.54 — upside +14%
Today : $111.59 — upside +31%
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
in progress (365j)
matures : Oct 16, 26
matures : Oct 16, 26
Evercore ISI Group ↗
Oct 16, 25
▲ Outperform · 🎯$142
Price at call : $128.54 — upside +10%
Today : $111.59 — upside +27%
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 16, 26
matures : Oct 16, 26
RBC Capital ↗
Oct 16, 25
▲ Outperform · 🎯$147
Price at call : $128.54 — upside +14%
Today : $111.59 — upside +32%
🎯 on ABT : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Oct 16, 26
matures : Oct 16, 26
Wells Fargo ↗
Oct 16, 25
▲ Overweight · 🎯$146
Price at call : $128.54 — upside +14%
Today : $111.59 — upside +31%
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Oct 16, 26
matures : Oct 16, 26
▲ Buy · 🎯$145
Price at call : $129.45 — upside +12%
Today : $111.59 — upside +30%
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Oct 15, 26
matures : Oct 15, 26
▲ Buy · 🎯$155
Price at call : $124.42 — upside +25%
Today : $111.59 — upside +39%
Expected +25% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-18.3%
stock -18% · XLV +21%
matured Jul 18, 26
Wells Fargo ↗
Jul 18, 25
▲ Overweight · 🎯$142
Price at call : $124.42 — upside +14%
Today : $111.59 — upside +27%
Expected +14% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-18.3%
stock -18% · XLV +21%
matured Jul 18, 26
Raymond James ↗
Jul 18, 25
▲ Outperform · 🎯$141
Price at call : $124.42 — upside +13%
Today : $111.59 — upside +26%
Expected +13% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
-18.3%
stock -18% · XLV +21%
matured Jul 18, 26
▲ Buy · 🎯$145
Price at call : $123.67 — upside +17%
Today : $111.59 — upside +30%
Expected +17% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
-17.8%
stock -18% · XLV +21%
matured Jul 18, 26
▲ Buy · 🎯$145
Price at call : $123.67 — upside +17%
Today : $111.59 — upside +30%
Expected +17% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-17.8%
stock -18% · XLV +21%
matured Jul 18, 26
Evercore ISI Group ↗
Jul 17, 25
▲ Outperform · 🎯$140
Price at call : $123.67 — upside +13%
Today : $111.59 — upside +25%
Expected +13% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-17.8%
stock -18% · XLV +21%
matured Jul 17, 26
▲ Buy · 🎯$148
Price at call : $131.49 — upside +13%
Today : $111.59 — upside +33%
Expected +13% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-32.1%
stock -32% · XLV +19%
matured Jul 14, 26
▲ Buy · 🎯$157
Price at call : $133.6 — upside +18%
Today : $111.59 — upside +41%
Expected +18% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-29.7%
stock -30% · XLV +18%
matured Jul 9, 26
Evercore ISI Group ↗
Jul 8, 25
▲ Outperform · 🎯$145
Price at call : $133.36 — upside +9%
Today : $111.59 — upside +30%
Expected +9% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-28.6%
stock -29% · XLV +20%
matured Jul 8, 26
▲ Buy · 🎯$145
Price at call : $129.89 — upside +12%
Today : $111.59 — upside +30%
Expected +12% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-26.1%
stock -26% · XLV +11%
matured Apr 17, 26
Raymond James ↗
Apr 17, 25
▲ Outperform · 🎯$142
Price at call : $129.89 — upside +9%
Today : $111.59 — upside +27%
Expected +9% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
-26.1%
stock -26% · XLV +11%
matured Apr 17, 26
Wells Fargo ↗
Apr 17, 25
▲ Overweight · 🎯$147
Price at call : $129.89 — upside +13%
Today : $111.59 — upside +32%
Expected +13% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-26.1%
stock -26% · XLV +11%
matured Apr 17, 26
Evercore ISI Group ↗
Apr 16, 25
▲ Outperform · 🎯$140
Price at call : $130.98 — upside +7%
Today : $111.59 — upside +25%
Expected +7% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-26.1%
stock -26% · XLV +10%
matured Apr 16, 26
▲ Buy · 🎯$160
Price at call : $137.71 — upside +16%
Today : $111.59 — upside +43%
Expected +16% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-19.4%
stock -19% · XLV +3%
matured Mar 4, 26
Wells Fargo ↗
Jan 23, 25
▲ Overweight · 🎯$136
Price at call : $123.22 — upside +10%
Today : $111.59 — upside +22%
Expected +10% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-12.8%
stock -13% · XLV +9%
matured Jan 23, 26
Raymond James ↗
Oct 14, 24
▲ Outperform · 🎯$129
Price at call : $116.05 — upside +11%
Today : $111.59 — upside +16%
Expected +11% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+11.6%
stock +12% · XLV -7%
matured Oct 14, 25
Evercore ISI Group ↗
Oct 1, 24
▲ Outperform · 🎯$124
Price at call : $113.64 — upside +9%
Today : $111.59 — upside +11%
Expected +9% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+17.0%
stock +17% · XLV -6%
matured Oct 1, 25
▲ Buy · 🎯$120
Price at call : $112.9 — upside +6%
Today : $111.59 — upside +8%
Expected +6% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+16.4%
stock +16% · XLV -12%
matured Aug 27, 25
▲ Buy · 🎯$127
Price at call : $112.69 — upside +13%
Today : $111.59 — upside +14%
Expected +13% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+17.0%
stock +17% · XLV -12%
matured Aug 22, 25
Evercore ISI Group ↗
Jul 2, 24
▲ Outperform · 🎯$120
Price at call : $102.33 — upside +17%
Today : $111.59 — upside +8%
Expected +17% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+31.4%
stock +31% · XLV -5%
matured Jul 2, 25
▲ Buy · 🎯$119
Price at call : $104.23 — upside +14%
Today : $111.59 — upside +7%
Expected +14% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+26.0%
stock +26% · XLV -10%
matured May 22, 25
Evercore ISI Group ↗
Apr 4, 24
▲ Outperform · 🎯$125
Price at call : $111.2 — upside +12%
Today : $111.59 — upside +12%
Expected +12% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+12.3%
stock +12% · XLV -6%
matured Apr 4, 25
▲ Buy · 🎯$128
Price at call : $110.11 — upside +16%
Today : $111.59 — upside +15%
Expected +16% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+13.0%
stock +13% · XLV -5%
matured Apr 3, 25
▲ Buy · 🎯$126
Price at call : $112.01 — upside +12%
Today : $111.59 — upside +13%
Expected +12% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+15.6%
stock +16% · XLV +6%
matured Jan 24, 25
Raymond James ↗
Jan 25, 24
▲ Outperform · 🎯$127
Price at call : $112.45 — upside +13%
Today : $111.59 — upside +14%
Expected +13% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+11.2%
stock +11% · XLV +4%
matured Jan 24, 25
Raymond James ↗
Jan 3, 24
▲ Outperform · 🎯$124
Price at call : $110.98 — upside +12%
Today : $111.59 — upside +11%
Expected +12% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+2.6%
stock +3% · XLV -0%
matured Jan 2, 25
Wells Fargo ↗
Dec 13, 23
▲ Overweight · 🎯$121
Price at call : $108.6 — upside +11%
Today : $111.59 — upside +8%
Expected +11% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
+4.4%
stock +4% · XLV +4%
matured Dec 12, 24
Wells Fargo ↗
Oct 19, 23
▲ Overweight · 🎯$116
Price at call : $96.78 — upside +20%
Today : $111.59 — upside +4%
Expected +20% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
+20.9%
stock +21% · XLV +18%
matured Oct 18, 24
Raymond James ↗
Oct 19, 23
▲ Outperform · 🎯$110
Price at call : $95.44 — upside +15%
Today : $111.59 — upside -1%
Expected +15% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+25.1%
stock +25% · XLV +19%
matured Oct 18, 24
Raymond James ↗
Apr 20, 23
▲ Outperform · 🎯$123
Price at call : $110.35 — upside +11%
Today : $111.59 — upside +10%
Expected +11% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
-2.8%
stock -3% · XLV +4%
matured Apr 19, 24
▲ Buy · 🎯$130
Price at call : $110.35 — upside +18%
Today : $111.59 — upside +16%
Expected +18% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-2.8%
stock -3% · XLV +4%
matured Apr 19, 24
▲ Buy · 🎯$130
Price at call : $104.15 — upside +25%
Today : $111.59 — upside +16%
Expected +25% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+1.7%
stock +2% · XLV +4%
matured Apr 16, 24
Raymond James ↗
Apr 17, 23
▲ Outperform · 🎯$116
Price at call : $104.52 — upside +11%
Today : $111.59 — upside +4%
Expected +11% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+4.5%
stock +4% · XLV +3%
matured Apr 16, 24
Wells Fargo ↗
Apr 10, 23
▲ Overweight · 🎯$136
Price at call : $103.7 — upside +31%
Today : $111.59 — upside +22%
Expected +31% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
+8.4%
stock +8% · XLV +7%
matured Apr 9, 24
Wells Fargo ↗
Apr 5, 23
▲ Overweight · 🎯$136
Price at call : $104.21 — upside +31%
Today : $111.59 — upside +22%
Expected +31% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
+5.7%
stock +6% · XLV +7%
matured Apr 4, 24
Raymond James ↗
Jan 26, 23
▲ Outperform · 🎯$123
Price at call : $111.07 — upside +11%
Today : $111.59 — upside +10%
Expected +11% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+0.9%
stock +1% · XLV +4%
matured Jan 26, 24
▲ Buy · 🎯$125
Price at call : $111.07 — upside +13%
Today : $111.59 — upside +12%
Expected +13% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+0.9%
stock +1% · XLV +4%
matured Jan 26, 24
▲ Outperform · 🎯$130
Price at call : $111.53 — upside +17%
Today : $111.59 — upside +16%
Expected +17% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
-3.8%
stock -4% · XLV -3%
matured Dec 13, 23
▲ Buy · 🎯$125
Price at call : $109.49 — upside +14%
Today : $111.59 — upside +12%
Expected +14% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-2.6%
stock -3% · XLV -4%
matured Dec 12, 23
Raymond James ↗
Oct 21, 22
▲ Outperform · 🎯$109
Price at call : $95.06 — upside +15%
Today : $111.59 — upside -2%
Expected +15% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+0.8%
stock +1% · XLV +1%
matured Oct 21, 23
▲ Buy · 🎯$114
Price at call : $95.21 — upside +20%
Today : $111.59 — upside +2%
Expected +20% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+1.7%
stock +2% · XLV +3%
matured Oct 20, 23
▲ Buy · 🎯$120
Price at call : $95.21 — upside +26%
Today : $111.59 — upside +8%
Expected +26% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+1.7%
stock +2% · XLV +3%
matured Oct 20, 23
Evercore ISI Group ↗
Oct 19, 22
▲ Outperform · 🎯$110
Price at call : $98.11 — upside +12%
Today : $111.59 — upside -1%
Expected +12% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-2.7%
stock -3% · XLV +3%
matured Oct 19, 23
▲ Buy · 🎯$123
Price at call : $103.52 — upside +19%
Today : $111.59 — upside +10%
Expected +19% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-11.0%
stock -11% · XLV +4%
matured Oct 17, 23
Wells Fargo ↗
Oct 10, 22
▲ Overweight · 🎯$140
Price at call : $101.13 — upside +38%
Today : $111.59 — upside +25%
Expected +38% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-3.5%
stock -4% · XLV +8%
matured Oct 10, 23
Wells Fargo ↗
Oct 9, 22
▲ Overweight · 🎯$150
Price at call : $101.13 — upside +48%
Today : $111.59 — upside +34%
Expected +48% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-4.3%
stock -4% · XLV +7%
matured Oct 9, 23
▲ Buy · 🎯$117
Price at call : $103.38 — upside +13%
Today : $111.59 — upside +5%
Expected +13% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-7.0%
stock -7% · XLV +1%
matured Oct 5, 23
▲ Buy · 🎯$140
Price at call : $110.06 — upside +27%
Today : $111.59 — upside +25%
Expected +27% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-5.6%
stock -6% · XLV +1%
matured Aug 19, 23
Wells Fargo ↗
Aug 4, 22
▲ Overweight · 🎯$150
Price at call : $109.72 — upside +37%
Today : $111.59 — upside +34%
Expected +37% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-1.9%
stock -2% · XLV +1%
matured Aug 4, 23
▲ Buy · 🎯$123
Price at call : $110.69 — upside +11%
Today : $111.59 — upside +10%
Expected +11% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+3.3%
stock +3% · XLV +5%
matured Jul 21, 23
Evercore ISI Group ↗
Jul 20, 22
▲ Outperform · 🎯$112
Price at call : $108.23 — upside +3%
Today : $111.59 — upside +0%
Expected +3% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+3.3%
stock +3% · XLV +5%
matured Jul 20, 23
▲ Buy · 🎯$126
Price at call : $109.93 — upside +15%
Today : $111.59 — upside +13%
Expected +15% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-2.4%
stock -2% · XLV +2%
matured Jul 18, 23
Raymond James ↗
Jul 15, 22
▲ Outperform · 🎯$117
Price at call : $108.82 — upside +8%
Today : $111.59 — upside +5%
Expected +8% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
-1.7%
stock -2% · XLV +1%
matured Jul 15, 23
▲ Outperform · 🎯$130
Price at call : $106.21 — upside +22%
Today : $111.59 — upside +16%
Expected +22% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+1.4%
stock +1% · XLV +2%
matured Jul 13, 23
Evercore ISI Group ↗
Jul 5, 22
▲ Outperform · 🎯$116
Price at call : $109.3 — upside +6%
Today : $111.59 — upside +4%
Expected +6% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-1.8%
stock -2% · XLV +2%
matured Jul 5, 23
▲ Buy · 🎯$130
Price at call : $109.45 — upside +19%
Today : $111.59 — upside +16%
Expected +19% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-0.9%
stock -1% · XLV +2%
matured Jun 24, 23
Raymond James ↗
Apr 21, 22
▲ Outperform · 🎯$135
Price at call : $123.37 — upside +9%
Today : $111.59 — upside +21%
Expected +9% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 58% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
-9.5%
stock -9% · XLV -3%
matured Apr 21, 23
Evercore ISI Group ↗
Apr 10, 22
▲ Outperform · 🎯$114
Price at call : $120.04 — upside -5%
Today : $111.59 — upside +2%
Expected -5% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-13.6%
stock -14% · XLV -5%
matured Apr 10, 23
Wells Fargo ↗
Apr 8, 22
▲ Overweight · 🎯$150
Price at call : $123.25 — upside +22%
Today : $111.59 — upside +34%
Expected +22% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-15.9%
stock -16% · XLV -7%
matured Apr 8, 23
Wells Fargo ↗
Feb 22, 22
▲ Overweight · 🎯$155
Price at call : $117.51 — upside +32%
Today : $111.59 — upside +39%
Expected +32% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 33% (12 calls matureds) · 📊 on Health : 48.5% · +1.2% (392 calls)
-12.6%
stock -13% · XLV +2%
matured Feb 22, 23
▲ Buy · 🎯$145
Price at call : $125.05 — upside +16%
Today : $111.59 — upside +30%
Expected +16% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
-24.0%
stock -24% · XLV -4%
matured Oct 21, 22
▲ Buy · 🎯$143
Price at call : $123.31 — upside +16%
Today : $111.59 — upside +28%
Expected +16% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-22.8%
stock -23% · XLV -5%
matured Oct 20, 22
▲ Outperform · 🎯$140
Price at call : $118.39 — upside +18%
Today : $111.59 — upside +25%
Expected +18% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
-14.6%
stock -15% · XLV -4%
matured Oct 8, 22
▲ Outperform · 🎯$140
Price at call : $115.53 — upside +21%
Today : $111.59 — upside +25%
Expected +21% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
-10.8%
stock -11% · XLV +1%
matured Oct 4, 22
▲ Buy · 🎯$136
Price at call : $126.37 — upside +8%
Today : $111.59 — upside +22%
Expected +8% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 25% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-18.8%
stock -19% · XLV -8%
matured Aug 31, 22
▲ Outperform · 🎯$140
Price at call : $125.84 — upside +11%
Today : $111.59 — upside +25%
Expected +11% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
-15.8%
stock -16% · XLV -5%
matured Aug 23, 22
▲ Buy · 🎯$130
Price at call : $120.92 — upside +8%
Today : $111.59 — upside +16%
Expected +8% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
-9.4%
stock -9% · XLV -1%
matured Aug 1, 22
▲ Outperform · 🎯$125
Price at call : $109.29 — upside +14%
Today : $111.59 — upside +12%
Expected +14% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+6.5%
stock +7% · XLV +6%
matured Jun 4, 22
▲ Outperform · 🎯$150
Price at call : $110.84 — upside +35%
Today : $111.59 — upside +34%
Expected +35% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+22.0%
stock +22% · XLV +15%
matured Jan 10, 22
▲ Buy · 🎯$123
Price at call : $109.48 — upside +12%
Today : $111.59 — upside +10%
Expected +12% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+15.8%
stock +16% · XLV +23%
matured Oct 22, 21
▲ Outperform · 🎯$113
Price at call : $108.04 — upside +5%
Today : $111.59 — upside +1%
Expected +5% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 50% (8 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+10.5%
stock +10% · XLV +21%
matured Oct 19, 21
▲ Buy · 🎯$113
Price at call : $96.01 — upside +18%
Today : $111.59 — upside +1%
Expected +18% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+29.7%
stock +30% · XLV +21%
matured Apr 17, 21
Evercore ISI Group ↗
Jan 3, 18
▲ Outperform · 🎯$64
Price at call : $58.92 — upside +9%
Today : $111.59 — upside -43%
Expected +9% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+12.4%
stock +12% · XLV -1%
matured Jan 3, 19
▲ Buy · 🎯$48
Price at call : $40.64 — upside +18%
Today : $111.59 — upside -57%
Expected +18% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+28.0%
stock +28% · XLV +16%
matured Sep 13, 17
▲ Buy · 🎯$52
Price at call : $45.26 — upside +15%
Today : $111.59 — upside -53%
Expected +15% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+8.9%
stock +9% · XLV +6%
matured Aug 4, 17
▲ Buy · 🎯$49
Price at call : $42.1 — upside +16%
Today : $111.59 — upside -56%
Expected +16% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+15.8%
stock +16% · XLV +8%
matured Jul 14, 17
▲ Buy · 🎯$45
Price at call : $37.43 — upside +20%
Today : $111.59 — upside -60%
Expected +20% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+28.6%
stock +29% · XLV +10%
matured Jun 14, 17
▲ Buy · 🎯$47
Price at call : $40.18 — upside +17%
Today : $111.59 — upside -58%
Expected +17% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+11.9%
stock +12% · XLV +13%
matured Mar 15, 17
▲ Buy · 🎯$47
Price at call : $36.71 — upside +28%
Today : $111.59 — upside -58%
Expected +28% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 75% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+11.7%
stock +12% · XLV +7%
matured Jan 26, 17
Evercore ISI Group ↗
May 27, 15
▲ Buy · 🎯$54
Price at call : $49.01 — upside +10%
Today : $111.59 — upside -52%
Expected +10% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on ABT : 42% (12 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-20.6%
stock -21% · XLV -6%
matured May 26, 16
Frequently asked questions
Should I buy Abbott Laboratories stock?
This isn't buy advice. For Abbott Laboratories, the analyst consensus is "Buy", with an average price target of $120 (+8% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Abbott Laboratories). We show the numbers — you decide.
Is it too late to buy Abbott Laboratories? How high can it go?
The most bullish analyst target on Abbott Laboratories is $143 (+28% above today's price); the average is $120. That's the upside they see. Check how reliable those analysts have actually been on Abbott Laboratories on our site before trusting it.
Is Abbott Laboratories still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 24 analysts have a real record on Abbott Laboratories, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Abbott Laboratories? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ABT (and why hesitate).
What has Abbott Laboratories's past performance been?
Historical returns and a "how much if I had invested" calculator: ABT performance & returns.
Does Abbott Laboratories pay a dividend?
Yield, consistency and growth history of the dividend: ABT's dividend.
What is the best month to buy ABT?
The 12 months ranked by the stock's past returns: best & worst month to buy ABT.
Are insiders buying ABT stock?
Executives' and large holders' buys and sells, decoded: insider buying on ABT.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX